These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9139842)

  • 61. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
    Nakamura T
    Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Seropositivity of anti-HTLV-II antibodies in patients with HTLV-I-associated myelopathy and adult T-cell leukemia].
    Nishimura Y; Yoshiki K; Yamaguchi K; Kiyokawa T; Takatsuki K
    Rinsho Byori; 1991 Dec; 39(12):1351-2. PubMed ID: 1779473
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High incidence of antibodies to HTLV-I tax in blood relatives of adult T cell leukemia patients.
    Okayama A; Chen YM; Tachibana N; Shioiri S; Lee TH; Tsuda K; Essex M
    J Infect Dis; 1991 Jan; 163(1):47-52. PubMed ID: 1984476
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pulmonary involvement in patients with human T lymphotropic virus type 1-associated myelopathy: the presence of specific IgA antibody in bronchoalveolar lavage fluid.
    Sugimoto M; Imamura F; Matsumoto M; Sonoda E; Cho I; Ando M
    Am J Trop Med Hyg; 1993 Jun; 48(6):803-11. PubMed ID: 8333573
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers.
    Akimoto M; Kozako T; Sawada T; Matsushita K; Ozaki A; Hamada H; Kawada H; Yoshimitsu M; Tokunaga M; Haraguchi K; Uozumi K; Arima N; Tei C
    J Med Virol; 2007 Jul; 79(7):977-86. PubMed ID: 17516523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lack of tax diversity for tropical spastic paraparesis/human T-cell lymphotropic virus type 1 (HTLV-I) associated myelopathy development in HTLV-I-infected subjects in São Paulo, Brazil.
    Casseb J; Fukumori L; Vergara M; Sanabani S; Marchiori P; Duarte A; Oliveira Ad
    Mem Inst Oswaldo Cruz; 2006 May; 101(3):273-6. PubMed ID: 16862321
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people.
    Chen YM; Lee TH; Samuel KP; Okayama A; Tachibana N; Miyoshi I; Papas TS; Essex M
    J Virol; 1989 Nov; 63(11):4952-7. PubMed ID: 2677406
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HTLV-1 antibody class and subclass distribution in African TSP and control populations.
    Verdier M; Bonis J; Leonard G; Dumas M; Denis F
    J Neuroimmunol; 1993 Jan; 42(1):117-20. PubMed ID: 8423204
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-I-associated disorders.
    Waldmann TA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S179-85. PubMed ID: 8797721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased expression of interleukin-2 receptor alpha on peripheral blood mononuclear cells in HTLV-I tax/rex mRNA-positive asymptomatic carriers.
    Okayama A; Tachibana N; Ishihara S; Nagatomo Y; Murai K; Okamoto M; Shima T; Sagawa K; Tsubouchi H; Stuver S; Mueller N
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 May; 15(1):70-5. PubMed ID: 9215657
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tuning Rex rules HTLV-1 pathogenesis.
    Nakano K; Watanabe T
    Front Immunol; 2022; 13():959962. PubMed ID: 36189216
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease.
    Lee SM; Dunnavant FD; Jang H; Zunt J; Levin MC
    Neurosci Lett; 2006 Jun; 401(1-2):188-93. PubMed ID: 16600502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.
    Sagara Y; Inoue Y; Tsujimura M; Kojima E; Shiraki H; Kashiwagi S
    Cancer Sci; 2004 Oct; 95(10):835-9. PubMed ID: 15504252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An enzyme-linked immunosorbent assay for immune complex of HTLV-I.
    Ishibashi K; Hanada S; Uozumi K; Otsuka M; Sakurami T; Hashimoto S
    J Immunol Methods; 1989 May; 119(2):217-21. PubMed ID: 2786036
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Infection of inbred rabbits with cell-free HTLV-I.
    Seto A; Isono T; Ogawa K
    Leuk Res; 1991; 15(2-3):105-10. PubMed ID: 2016902
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IgG autoantibody response in HTLV-I-infected patients.
    Muller S; Boire G; Ossondo M; Ricchiuti V; Smadja D; Vernant JC; Ozden S
    Clin Immunol Immunopathol; 1995 Dec; 77(3):282-90. PubMed ID: 7586738
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously.
    Parker CE; Nightingale S; Taylor GP; Weber J; Bangham CR
    J Virol; 1994 May; 68(5):2860-8. PubMed ID: 7512153
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.
    Rudolph DL; Coligan JE; Lal RB
    Clin Diagn Lab Immunol; 1994 Mar; 1(2):176-81. PubMed ID: 7496941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of anti-HTLV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay-negative individuals.
    Ehrlich GD; Glaser JB; Abbott MA; Slamon DJ; Keith D; Sliwkowski M; Brandis J; Keitelman E; Teramoto Y; Papsidero L
    Blood; 1989 Aug; 74(3):1066-72. PubMed ID: 2752152
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intrafamilial transmission of HTLV-I and its association with anti-Tax antibody in an endemic population in Japan.
    Shioiri S; Stuver SO; Okayama A; Murai K; Shima T; Tachibana N; Tsubouchi H; Essex M; Mueller N
    Int J Cancer; 1998 Jan; 75(1):15-8. PubMed ID: 9426684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.